$600.50
4.07% yesterday
NYSE, Nov 20, 10:10 pm CET
ISIN
US91324P1021
Symbol
UNH

UnitedHealth Stock price

$600.50
+29.03 5.08% 1M
+83.27 16.10% 6M
+74.03 14.06% YTD
+65.40 12.22% 1Y
+162.96 37.24% 3Y
+324.94 117.92% 5Y
+503.65 520.03% 10Y
NYSE, Closing price Wed, Nov 20 2024
+23.50 4.07%
ISIN
US91324P1021
Symbol
UNH
Sector

Key metrics

Market capitalization $552.63b
Enterprise Value $608.16b
P/E (TTM) P/E ratio 39.01
EV/FCF (TTM) EV/FCF 46.44
EV/Sales (TTM) EV/Sales 1.55
P/S ratio (TTM) P/S ratio 1.41
P/B ratio (TTM) P/B ratio 5.86
Dividend yield 1.36%
Last dividend (FY24) $8.18
Revenue growth (TTM) Revenue growth 9.66%
Revenue (TTM) Revenue $392.72b
EBIT (operating result TTM) EBIT $31.02b
Free Cash Flow (TTM) Free Cash Flow $13.10b
EPS (TTM) EPS $15.39
P/E forward 38.05
P/S forward 1.38
EV/Sales forward 1.52
Short interest 0.77%
Show more

Create a Free Account to create an UnitedHealth alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

UnitedHealth Stock Analysis

Analyst Opinions

30 Analysts have issued a UnitedHealth forecast:

25x Buy
83%
5x Hold
17%

Analyst Opinions

30 Analysts have issued a UnitedHealth forecast:

Buy
83%
Hold
17%

Financial data from UnitedHealth

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
392,719 392,719
9% 9%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 98,282 98,282
8% 8%
25%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 4,032 4,032
1% 1%
1%
EBIT (Operating Income) EBIT 31,024 31,024
2% 2%
8%
Net Profit 14,317 14,317
34% 34%
4%

In millions USD.

Don't miss a Thing! We will send you all news about UnitedHealth directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

UnitedHealth Stock News

Neutral
CNBC
one day ago
CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional.  The complaint is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.
Negative
Reuters
9 days ago
The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market for home health services, the department said.
Negative
Reuters
9 days ago
The U.S. Justice Department is moving to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home health services, Bloomberg News reported on Tuesday, citing people familiar with the matter.
More UnitedHealth News

Company Profile

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health services business serving the broad health care marketplace, including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the health care industry. The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.

Head office United States
CEO Andrew Witty
Employees 440,000
Founded 1977
Website www.unitedhealthgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today